-
Navigating the challenges of the Manulife-Loblaw PPN arrangement
Deals like the recent preferred provider agreement to supply specialty drugs are not only anti-competitive for business, they also restrict patients’ choice of where to obtain healthcare and ultimately, reduce the incentives for pharmacies to innovate.